The pleckstrin homology domain of phospholipase D1 accelerates EGFR endocytosis by increasing the expression of the Rab5 effector, rabaptin-5

Sorkin A, von Zastrow M . Endocytosis and signalling: intertwining molecular networks. Mol Cell Biol 2009; 10: 609–622.

Lee CS, Kim KL, Jang JH, Choi YS, Suh PG, Ryu SH . The roles of phospholipase D in EGFR signaling. Biochim Biophys Acta 2009; 1791: 862–868.

Kang DW, Choi CY, Cho YH, Tian H, Di Paolo G, Choi KY et al. Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells. J Exp Med 2015; 212: 1219–1237.

Hwang WC, Kim MK, Song JH, Choi KY, Min DS . Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells. Exp Mol Med 2014; 46: e124.

Jang YH, Choi KY, Min DS . Phospholipase D-mediated autophagic regulation is a potential target for cancer therapy. Cell Death Differ 2014; 21: 533–546.

Kang DW, Choi K, Min DS . Functional regulation of phospholipase D expression in cancer and inflammation. J Biol Chem 2014; 289: 22575–22582.

Jang JH, Lee CS, Hwang D, Ryu SH . Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog Lipid Res 2012; 51: 71–81.

Jenkins GM, Frohman MA . Phospholipase D: a lipid centric review. Cell Mol Life Sci 2005; 62: 2305–2316.

Lee CS, Kim IS, Park JB, Lee MN, Lee HY, Suh PG et al. The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis. Nat Cell Biol 2006; 8: 477–484.

Stenmark H, Parton RG, Steele-Mortimer O, Lütcke A, Gruenberg J, Zerial M . Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 1994; 13: 1287.

Harris AL . Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38–47.

Semenza GL . Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721–732.

Wang Y, Roche O, Yan MS, Finak G, Evans AJ, Metcalf JL et al. Regulation of endocytosis via the oxygen-sensing pathway. Nat Med 2009; 15: 319–324.

Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastase. Cancer Res 1999; 59: 5830–5835.

Park MH, Choi KY, Jung Y, Min DS . Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability. Oncotarget 2014; 5: 11857–11872.

Min DS, Ahn BH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS et al. Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells. Neuropharmacol 2001; 41: 384–391.

Park MH, Ahn BH, Hong YK, Min DS . Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis 2009; 30: 356–365.

Pfeffer SR . Motivating endosome motility. Nat Cell Biol 1999; 1: E145–E147.

Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B et al. The small GTPase rab5 functions as regulatory factor in the early endocytic pathway. Cell 1992; 70: 729–740.

Korobko EV, Palgova IV, Kiselev SL, Korobko IV . Apoptotic cleavage of rabaptin-5-like proteins and a model for rabaptin-5 inactivation in apoptosis. Cell Cycle 2006; 5: 1854–1858.

Stenmark H, Vitale G, Ullrich O, Zerial M . Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell 1995; 83: 423–432.

Du G, Huang P, Liang BT, Frohman MA . Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell 2004; 15: 1024–1030.

Shen Y, Xu L, Foster DA . Role for phospholipase D in receptor-mediated endocytosis. Mol Cell Biol 2001; 21: 595–602.

Henley JR, Krueger EW, Oswald BJ, McNiven MA . Dynamin-mediated internalization of caveolae. J Cell Biol 1998; 141: 85–99.

Blume-Jensen P, Hunter T . Oncogenic kinase signalling. Nature 2001; 411: 355–365.

Franovic A, Gunaratnam L, Smith KRI, Patten D, Lee S . Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci USA 2007; 104: 13092–13097.

Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM . Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347–361.

Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM et al. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 1999; 19: 5902–5912.

Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci USA 2012; 109: 4892–4897.

Donaldson JG . Phospholipase D in endocytosis and endosomal recycling pathways. Biochim Biophys Acta 2009; 1797: 845–849.

Selvy PE, Lavieri RR, Lindsley CW, Brown HA . Phospholipase d: enzymology, functionality, and chemical modulation. Chem Rev 2011; 111: 6064–6119.

Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A, York JD et al. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol 2000; 151: 1353–1368.

Lee JS, Kim IS, Kim JH, Cho W, Suh PG, Ryu SH . Determination of EGFR endocytosis kinetic by auto-regulatory association of PLD1 with mu2. PLoS One 2009; 4: 7090.

Avraham R, Yarden Y . Feedback regulation of EGFR signalingLdecision making by early and delayed loops. Nat Rev Mol Cell Biol 2011; 12: 104–117.